Ligand Pharma (LGND) Shares Add 4+% After Hours as FDA Panel Votes In Favor of Onyx's (ONXX) Carfilzomib

Article Stock Quotes (2) Comments (0)

Shares of Ligand Pharma (Nasdaq: LGND) are now up another 4 percent in Wednesday's after-hours session following news an FDA panel voted 11-0 that the benefits of Onyx Pharma's (Nasdaq: ONXX) carfilzomib outweigh the risks. Ligand shares closed the session up nearly 13 percent.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Highway Holdings (HIHO) Halted Again on Circuit Breaker; Last Up 80%
• Crash in American Electric Power (AEP) & NextEra Energy (NEE) Adds to Jitters
• Cleantech Solutions (CLNT) Goes Red to Green After Yesterday's 159% Rise

Create E-mail Alert Related Categories

Momentum Movers, Trader Talk

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?